Loading
Latest filing published 04 Mar 2023 for LSL Pharma Group Inc..
No signal scores available.
Marc Boudreault discloses dealings in LSL Pharma Group Inc. to SEDI. In total, 2 filings cover trades dated 22 February 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 4 March 2023, reports a transaction in LSL Pharma Group Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations